AVEVA Drug Delivery Systems Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 recall — FDA D-0466-2023
Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.